Regulation - North America


Current filters:

North America

Popular Filters

1030 to 1054 of 3305 results

Novartis' Lucentis first drug approved in EU for myopic choroidal neovascularization


The European Commission has granted Swiss drug major Novartis (NOVN: VX) a new indication for Lucentis…


Indian pharma threatened by trend of shifting R&D operations overseas: survey


Red tape is putting India's multi-billion dollar worth pharmaceutical industry at risk, with most of…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Orexo gets US FDA approval for opioid dependence drug Zubsolv


Swedish drug developer Orexo (STO: ORX) today (July 4) received approval from the US Food and Drug Administration…

Orexo ABPharmaceuticalReckitt BenckiserRegulationSuboxoneZubsolv

Next generation sequencing market expected to grow to $2.7 billion by 2017


The next generation sequencing (NGS) market has been forecast to increase at a compound annual growth…

BiotechnologyEuropeGeneticsIlluminaMarkets & MarketingNorth America

Impax Labs confirms patent challenge to Pfizer/UCB's Toviaz


US specialty drugmaker Impax Laboratories (Nasdaq: IPXL) yesterday confirmed that it has initiated a…

Gastro-intestinalsGenericsImpax LaboratoriesNorth AmericaPatentsPfizerToviazUCB

Roche granted FDA Priority Review for obinutuzumab in the treatment of chronic lymphocytic leukemia


Swiss drug major Roche (ROG: SIX) has announced today (July 3) that the US Food and Drug Administration…


EFPIA releases code on financial relations with health care professionals


The European Federation of Pharmaceutical Industries and Associations (EFPIA) has released its disclosure…

BiotechnologyEuropeFinancialMarkets & MarketingPharmaceuticalRegulation

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards


From July 2, 2013, all active substances manufactured outside of the European Union and imported into…


Avanir in up to $110 million deal with OptiNose for migraine product


US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into an exclusive North American license…

Avanir PharmaceuticalsLicensingNeurologicalNorth AmericaOptiNosePharmaceuticalsumatriptan

US FDA backs news indications for Latuda; grants Priority Review for Perjeta


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506), says that…

BiotechnologyDainippon Sumitomo PharmaLatudaNeurologicalNorth AmericaOncologyPerjetaPharmaceuticalRegulationRocheSunovion

US FDA delays Merck & Co's insomnia drug suvorexant, issuing CRL


There was disappointment for US drug giant Merck & Co (NYSE: MRK), which said that it has received a…

Merck & CoNeurologicalNorth AmericaPharmaceuticalRegulationsuvorexant

First nationally-consistent list of hospital medicines takes effect in New Zealand


People in New Zealand will be able to get the same medicines whichever hospital they visit, as a result…


Setback for Janssen and Bayer's Xarelto as FDA calls for more info in stent thrombosis setting for ACS patients


Janssen Research & Development, a unit of US health care giant Johnson & Johnson (NYSE: JNJ) revealed…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Noven's Brisdelle is first non-hormonal treatment for menopausal hot flashes to be approved by FDA


The US Food and Drug Administration on Friday (June 28) approved Noven Pharmaceuticals' Brisdelle (paroxetine)…

BrisdelleHisamitsu PharmaNorth AmericaNoven PharmaceuticalsparoxetinePharmaceuticalRegulationWomen's Health

Chugai gains Japanese approval for Perjeta and Bonviva


Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) said this morning (June 28) that it has obtained…

Anti-Arthritics/RheumaticsAsia-PacificBonvivaChugai PharmaceuticalOncologyPerjetaPharmaceuticalRegulationRoche

FDA backs Baxter's Rixubis for hemophilia B; Breakthrough status for GSK's drisapersen


The US Food and Drug Administration yesterday (June 27) approved Baxter International's (NYSE: BAX) Rixubis…

Baxter InternationaldrisapersenGlaxoSmithKlineNorth AmericaPharmaceuticalRare diseasesRegulationRixubis

1030 to 1054 of 3305 results

Back to top